期刊文献+

进行性核上性麻痹的临床表现和神经影像学特点 被引量:5

Clinical and neuroimaging characteristics of progressive supranuclear palsy
下载PDF
导出
摘要 目的探讨进行性核上性麻痹(progressive supranuclear palsy,PSP)的临床特点及头颅MRI、正电子发射体层扫描(PET)检查在本病中的诊断价值。方法回顾性分析19例PSP患者临床特点、神经影像学特征。结果19例PSP患者中,12例患者以走路不稳、反复向后跌倒为首发.17例患音出现垂直性核上性眼肌麻痹,假性球麻痹出现较早,还伴有轴性肌张力障碍、轻度痴呆等症状。19例患者均行头颅MRI检查,10例患者正中矢状位可见中脑上端萎缩,呈"蜂鸟征",水平位可见中脑前后径变小,呈"鼠耳征",1例患者中脑被盖和顶盖部T_2加权像显示弥散性高信号,中脑萎缩随病程加重。13例患者PET检查,均可见中脑葡萄糖代谢降低,双侧额叶葡萄糖代谢降低比较明显,部分合并顶叶或顶枕联合区葡萄糖代谢降低。结论 PSP临床表现变异较大,但通过头颅MRI、PET等辅助检查的特征性表现,可为诊断及鉴别诊断提供依据。 Objective To explore the clinical features and value of MR1 and ^18F-FDG PET in diagnosis of progressive supranuclear palsy(PSP). Methods Retrospective analysis was conducted on clinical and neuroimaging features of 19 patients with clinically diagnosed probable PSP. Results The initial symptoms of PSP were walking instability and falls. Characteristically, supranuclear gaze deficits in PSP involved initially either downward or upward gaze. False bulbar palsy could be observed early, accompanied by axial dystonia and mild dementia symptoms. Cranial MRI scan was applied in all 19 patients. On mid-sagittal plane MRI,there were atrophy in upper part of the mid- brain and hummingbird sign. On horizontal plane MRI, reduction of anteroposterior diameter of midbrain and mouse ears sign were observed. Hyperintense signal was found on T2 WI MR image of the midbrain tegmentum and tectum of tients,and showed that glucose metabolism presented reduction of glucose metabolism one patient. 18 F-FDG PET was performed in 13 pa- in midbrain of all patients was low,some of them also in bilateral frontal and parietal lobes. Conclusion Some clinical characteristics of PSP are special, some auxiliary examinations, such as MRI and PET, are important for making the diagnosis and differential diagnosis.
作者 刘红 张本恕
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2009年第2期119-122,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 核上麻痹 进行性 磁共振成像 正电子发射断层显像术 神经系统疾病 诊断 supranuclear palsy, progressive magnetic resonance imaging positron-emission tomography nervous system diseases diagnosis
  • 相关文献

参考文献11

  • 1Litvan I ,Bhatia KP,Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord, 2003,18 : 467-486.
  • 2Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: pathology and genetics. Brain Pathol, 2007,17: 74-82.
  • 3Dubois B,Slachevsky A,Pillon B,et al. "Applause sign"helps to discriminate PSP from FTD and PD. Neurology, 2005,64 : 2132-2133.
  • 4Krishnan S, Mathuranath PS,Sarma S, et al. Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson' s disease. Neurol India, 2006,54 268-272.
  • 5Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuelear paLsy. J Neurol Sei, 2003, 210:57-60.
  • 6Righini A, Antonini A, De Notaris R, et al. MR imaging of the superior profile of the midbrain : differential diagnosis between progressive supranuclear palsy and Parkinson disease. Am J Neuroradiol, 2004,25 : 927-932.
  • 7Adams R, Victor M, Ropper AH. Principles of neurology. Sixth ed. New York: McGraw Hill, 1997. 1076-1078.
  • 8Ito K, Arai K, Yoshiyama Y, et al. Astroeytic tau pathology positively correlates with neurofibrillary tangle density in pro- gressive supranuclear palsy. Acta Neuropathol, 2008, 115: 623-628.
  • 9Quattrone A,Nicoletti G,Messina D,et al. MR imaging index for differentiation of progressive supranuelear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology, 2008,246 : 214-221.
  • 10Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology, 2005,64:2050-2055.

同被引文献32

  • 1侯静,陈彤,张晓红,吴卫平,王振福,郭瑞表.103例国人进行性核上性麻痹患者的临床特征[J].神经病学与神经康复学杂志,2010,7(3):135-141. 被引量:14
  • 2傅毅,何文绮,刘建荣,陈生弟.5例进行性核上性麻痹遗传和临床特点的探讨[J].脑与神经疾病杂志,2005,13(6):414-416. 被引量:6
  • 3Gearing M,Olson DA,Watts RL,et al.Progressive supranuclear palsy: Neuropathologic and clinical heterogeneity[J]. Neurology, 1994,44(6): 1015-1024.
  • 4Wakabayashi K, Takahashi H.Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration [J]. Neuropathology,2004,24(1):79-86.
  • 5Litvanl,A gid Y, Calne D,et al.Clinical research criteria forthe diagno- sis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome):report of the NINDS2 SPSP intemationalwork shop [J]. Neurology, 1996,47( 1): 129.
  • 6Rol|and , Verin M, Payan CA, et al. A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. J Neurol Neurosurg Psychiatry,2011,82 : 1025.
  • 7Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Sci- entific Issues Committee report: SIC Task Force appraisal of ehnlcal diagnostic criteria for Parkinsonian disorders. Mov Disord,2003,18 : 467.
  • 8Hughes A J, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson disease:a clinico-pathologieal study of 100 cases. J Neurol Neurosurg Psychiatry, 1992,55 : 181.
  • 9Armstrong RA, Lantos PL, Cairns NJ. Spatial topography of the neu-rofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy. Parkinsonism & Related Disorders ,2007,13:50.
  • 10Tsukamoto K, Matsusue E, Kanasaki Y, et al. Significance of appar- ent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Par- kinson disease: evaluation by 3.0-T MR imaging. Neuroradiology, 2012,54:947.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部